𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MMP2 promoter polymorphism (C-1306T) and risk of recurrence in patients with hepatocellular carcinoma after transplantation

✍ Scribed by LM Wu; F Zhang; HY Xie; X Xu; QX Chen; SY Yin; XC Liu; L Zhou; XB Xu; YL Sun; SS Zheng

Book ID
110888551
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
97 KB
Volume
73
Category
Article
ISSN
0009-9163

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

MDR1 gene polymorphisms and risk of recu
MDR1 gene polymorphisms and risk of recurrence in patients With hepatocellular carcinoma after liver transplantation
✍ Liming Wu; Xiaobo Xu; Juwei Shen; Haiyang Xie; Songfeng Yu; Tingbo Liang; Weilin πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract ## Background and Objectives Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) remains a major cause of post‐LT death. However, currently there is still lacking the markers to reliably predict recurrence. This study was undertaken to evaluate the association

Total tumor volume predicts risk of recu
Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma
✍ Christian Toso; James Trotter; Alice Wei; David L. Bigam; Shimul Shah; Joshua La πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 241 KB

Criteria for the selection of candidates for liver transplantation in the presence of hepatocellular carcinoma (HCC) should accurately predict posttransplant recurrence while not excluding excessive numbers of patients from candidacy. Existing criteria are challenged by the limited accuracy of radio